SIRTUINS AS PERSPECTIVE TARGET FOR PREVENTION AND TREATMENT OF DIABETES

Authors

DOI:

https://doi.org/10.21856/j-PEP.2014.3.13

Keywords:

type 2 diabetes, sirtuin, alpha-lipoic acid.

Abstract

The review is devoted to the role of sirtuins, particularly SIRT1, in the regulation of processes
involved in the pathogenesis of obesity, insulin resistance, type 2 diabetes and its vascular complica-
tions. Proved the perspectivity of SIRT1 use as a therapeutic target for patients with diabetes, and
also describes a mechanism for activating SIRT1 in vitro and in vivo by alpha-lipoic acid.

References

IDF Diabetes Atlas , Fifth Ed., 2011.

Diabetes Care 2012; 35(1):S64-S71.

Seshasai SR, Kaptoge S, Thompson A, et al. N Engl J Med 2011; 364:829-841.

BMJ 2000; 321:405-412.

Bordone L, Guarente L. Nat Rev Mol Cell Biol 2005; 6(4):298-305.

Boily G, Seifert EL, Bevilaqua L, et al. PLoS One 2008; 3:e1759.

Colman RJ, Anderson RM, Johnson SC, et al. Science 2009; 325:201-204.

Fontana L, Meyer TE, Klein S, et al. Proc Natl Acad Sci USA 2004; 101:6659-6663.

Imai S, Armstrong CM, Kaeberlein M, Guarente L. Nature 2000; 403:795-800.

Smith JS, Brachmann CB, Celic I, et al. Proc Natl Acad Sci USA 2000; 97:6658-6663.

Ramkumar R, Richa G, Marija KD, Constantinos D. J Biomed Biotechnol 2011; 2011:1-17.

Vaquero A, Scher M, Lee D, et al. Mol Cell 2004; 16:93-105.

Oberdoerffer P, Michan S, McMay M, et al. Cell 2008; 135:907-918.

Vaziri H, Dessain SK, Eaton ENg, et al. Cell 2001; 107:149-159.

Kitada M, Kume S, Takeda-Watanabe A, et al. Clin Sci (Lond) 2013; 124:153-164.

Picard F, Kurtev M, Chung N, et al. Nature 2004; 429:771-776.

Purushotham A, Shug TT, Xu Q, et al. Cell Metab 2009; 9:327-338.

Nakahata Y, Kaluzova M, Grimaldi B, et al. Cell 2008; 134:329-340.

Brunet A, Sweeney LB, Sturgill JF, et al. Science 2004; 303:2011-2015.

Kitada M, Koya D. Diabetes Metab 2013; 37:315-325.

EMBO J 2004; 23:2369-2380.

Cheng Y, Takeuchi H, Sonobe Y, et al. J Neuroimunol 2014; 269:38-43.

Mattagajasingh I, Kim CS, Naqvi A, et al. Proc Natl Acad Sci USA 2007; 104:14855-14860.

Lan F, Cacicedo GM, Ruderman N, Ido Y. J Biol Chem 2008; 283:27628-27635.

Jager S, Handschin C, St-Pierre J, Spiegelman BM. PNAS 2007; 104:12017-12022.

Liu Y, Dentin R, Chen D, et al. Nature 2008; 456:269-273.

Li X, Zhang S, Blander G, et al. Mol Cell 2007; 28:91-106.

Kemper JK, Xiao Z, Ponugoti B, et al. Cell Metab 2009; 10:392-404.

Bordone L, Motta MC, Picard F, et al. PLoS 2006; 4:e31.

Wang H, Kouri G, Wollheim CB. J Cell Sci 2005; 118:3905.

Sun C, Zhang F, Ge X, et al. Cell Metab 2007; 6:307-319.

Holmes BF, Sparling DP, Olson AL, et al. Am J Physiol Endocrinol Metab 2005; 289:E1071-E1076.

Rodgers JT, Lerin C, Haas W, et al. Nature 2005; 434:113-118.

Lagouge M, Argmann C, Gerhard-Hines Z, et al. Cell 2006; 127:1109-1122.

De Kreutzenberg SV, Ceolotto G, Papparella I, et al. Diabetes 2010; 59:1006-1015.

Gillum MP, Kotas ME, Erion DM, et al. Diabetes 2011; 60:3235-3245.

Frojdo S, Durand C, Molin L, et al. Mol Cell Endocrinol 2011; 335:166-176.

Lee JH, Song MY, Song EK, et al. Diabetes 2009; 58:344-351.

Gerhard-Hines Z, Rodgers JT, Bare O, et al. EMBO J 2007; 26:1913-1923.

Förstermann U. Nat Clin Pract Cardiovasc Med 2008; 5(6):338-349.

Brownlee M. Nature 2001; 414:813-820.

Edeas M, Attaf D, Mailfert AS, et al. Pathol Biol (Paris) 2010; 58(3):220-225.

Brownlee M. Diabetes 2005; 54:1615-1625.

Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Endocrine Rev 2002; 23(5):599-622.

Sivitz WI, Yorek MA. Antioxid Redox Signal 2010; 12(4):537-577.

El-Osta A, Brasacchio D, Yao D, et al. J Exp Med 2008; 205:2409-2417.

Ihnat MA, Thorpe JE, Kamat CD, et al. Diabetologia 2007; 50:1523-1531.

Zhou S, Chen HZ, Wan YZ, et al. Circ Res 2011; 109:639-648.

Paneni F, Mochara P, Akhmedov A, et al. Circ Res 2012; 111:278-289.

Paneni F, Volpe M, Luscher TF, Cosentino F. Diabetes 2013; 62:1800-1807.

St-Pierre J, Drori S, Uldry M, et al. Cell 2006; 127:397-408.

Hasegava K, Wakino S, Yoshioka K, et al. Biochem Biophys Res Commun 2008; 372:51-56.

Baur JA. Biochem Biophys Acta 2010; 1804:1626-1634.

Farghali H, Kutinova Canova N, Lekic N. Physiol Res 2013; 62:1-13.

Chen WL, Kang CH, Wang SG, Lee HM. Diabetologia 2012; 55:1824-1835.

Valdecantos MP, Perez-Matute P, Gonzalez-Muniesa P, et al. Obesity 2012; 20:1974-1983.

Zhang WJ, Frei B. FASEB 2001; 15:2423-2432.

Singh U, Jialal I. Nutr Rev 2008; 66(11):646-657.

Rochette L, Ghibu S, Richard C, et al. Mol Nutr Res 2013; 57:114-125.

Poltorak VV, Krasova NS, Gorshunskaja MJu. Probl Endokryn Patologii’ 2012; 3:91-103.

Valdecantos MP, Perez-Matute P, Gonzalez-Muniesa P, et al. J Nutr Biochem 2012; 23:1676-1684.

Packer L, Cadenas E. J Clin Biochem Nutr 2011; 48:26-32.

Teichert J, Kern J, Tritschler HJ, et al. Int J Clin Pharmacol Ther 1998; 36:625-628.

Teichert J, Hermann R, Ruus P, Preiss R. J Clin Pharmacol 2003; 43:1257-1267.

Keith DJ, Butler JA, Bemer B, et al. Pharmacol Res 2012; 66:199-206.

Downloads

Published

2014-10-27

How to Cite

Poltorak, V., Krasova, N., & Gorshunska, M. (2014). SIRTUINS AS PERSPECTIVE TARGET FOR PREVENTION AND TREATMENT OF DIABETES. Problems of Endocrine Pathology, 49(3), 97-104. https://doi.org/10.21856/j-PEP.2014.3.13

Most read articles by the same author(s)

1 2 > >>